ANALYSIS OF DRUG INTERACTIONS BETWEEN GLP-1 RECEPTOR AGONISTS AND MEDICATIONS USED IN THE TREATMENT OF CARDIOMETABOLIC DISEASES

Authors

DOI:

https://doi.org/10.51891/rease.v12i11.32920

Keywords:

Drug interactions, GLP-1 receptor agonists, Cardiometabolic diseases

Abstract

Drug interactions involving glucagon-like peptide-1 (GLP-1) receptor agonists and medications used to treat cardiometabolic diseases deserve attention due to their potential effects on pharmacotherapy safety. Accordingly, this study aimed to analyze these interactions through a documentary, descriptive study with a qualitative approach, based on information available on the Drugs.com platform. Interactions involving semaglutide, liraglutide, dulaglutide, exenatide, lixisenatide, and tirzepatide were analyzed in combination with medications used to treat diabetes mellitus, hypertension, and dyslipidemia. The results showed that the identified interactions were mainly related to glycemic control and renal function. The main findings included the risk of hypoglycemia when these drugs are combined with certain antidiabetic agents and the possibility of renal alterations in some combinations, particularly those involving exenatide. These findings highlight the importance of identifying potential drug interactions to promote the safe use of these treatments and help prevent complications. It is concluded that pharmacotherapeutic monitoring is essential for assessing the risks associated with drug combinations and supporting safer treatment tailored to each patient's needs.

0 0

Downloads

Download data is not yet available.

Author Biographies

  • Isabela Silva Ribeiro Bezerra, Centro Universitário Santo Agostinho

    Graduanda em Farmácia pelo Centro Universitário Santo Agostinho (UNIFSA). 

  • Samira dos Santos Ferreira, Centro Universitário Santo Agostinho

    Graduanda em Farmácia pelo Centro Universitário Santo Agostinho (UNIFSA). 

  • Joubert Aires de Sousa, Centro Universitário Santo Agostinho

    Orientador. Docente da Universidade Estadual do Piauí (Centro de Ciências da Saúde) e do Centro Universitário Santo Agostinho (UNIFSA). Farmacêutico habilitado em Análises Clínicas (UFPI). Mestre em Farmacologia (UFPI). Especialista em Farmacologia (UFLA-MG). Doutor em Biologia Molecular e Celular (ULBRA-RS). 

Published

2026-11-17

How to Cite

Bezerra, I. S. R., Ferreira, S. dos S., & Sousa, J. A. de. (2026). ANALYSIS OF DRUG INTERACTIONS BETWEEN GLP-1 RECEPTOR AGONISTS AND MEDICATIONS USED IN THE TREATMENT OF CARDIOMETABOLIC DISEASES. Revista Ibero-Americana de Humanidades, Ciências E Educação, 12(11), 1-17. https://doi.org/10.51891/rease.v12i11.32920

Most read articles by the same author(s)

Similar Articles

1-10 of 50

You may also start an advanced similarity search for this article.